This article is maintained by: Elsevier
Article Title: Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment
Journal Title: Reumatología Clínica (English Edition)
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2022.06.001
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2022.01.003
Content Type: simple-article
Copyright: © 2022 Published by Elsevier España, S.L.U.